Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,087 | 9,650 | 8,046 | 8,645 | 2,599 |
| Receivables | 3,370 | 4,592 | 5,505 | 3,894 | 5,279 |
| Inventories | 3,605 | 3,189 | 3,747 | 3,848 | 2,602 |
| TOTAL | $17,180 | $18,531 | $18,007 | $17,118 | $11,234 |
| Non-Current Assets | |||||
| PPE Net | 1,872 | 1,978 | 1,823 | 1,833 | 1,656 |
| Intangibles | 300 | 327 | 354 | 350 | 375 |
| Other Non-Current Assets | 4,093 | 3,651 | 4,143 | 4,241 | 4,209 |
| TOTAL | $6,265 | $5,956 | $6,320 | $6,424 | $6,240 |
| Total Assets | $23,445 | $24,487 | $24,326 | $23,542 | $17,473 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,269 | 4,310 | 3,935 | 3,929 | 3,190 |
| Other current liabilities | N/A | N/A | N/A | N/A | 23 |
| TOTAL | $3,269 | $4,310 | $3,935 | $3,929 | $3,213 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,269 | $4,310 | $3,935 | $3,929 | $3,213 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,564 | 9,325 | 9,325 | 9,325 | 9,286 |
| Common Shares | 95 | 93 | 93 | 93 | 81 |
| Retained earnings | -27,016 | -26,791 | -26,529 | -27,246 | -27,005 |
| TOTAL | $20,177 | $20,177 | $20,391 | $19,613 | $14,261 |
| Total Liabilities And Equity | $23,445 | $24,487 | $24,326 | $23,542 | $17,473 |